Stock Events

Stock Events

Halozyme Therapeutics (RV7.F) Q2 2024 Earnings

7MayConfirmed

Q3 2023

Q4 2023

Q1 2024

Q2 2024

0.57

0.63

0.69

0.76

Details

Expected EPS

0.6384729

Actual EPS

0.7347

Surprise EPS

0.1

Surprise Percent

+15.07%

Description

Halozyme Therapeutics (RV7.F) has reported earnings of 0.7347 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.